Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Molecular Detection of Advanced Neoplasia in Pancreatic Cysts

NCT03855800 · View on ClinicalTrials.gov ↗

Study Summary

Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Blood, stool, pancreatic juice and cyst fluid collection
  • PROCEDURE Pancreatic Surgery
  • PROCEDURE Endoscopy Exam

Study Locations (1)

Minnesota

  • Mayo Clinic — Rochester

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2018-05-11
Est. Completion 2030-12-30
Phase NA

Sponsor

Mayo Clinic

3,246 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03855800

The ClinicalTrials.gov registry entry for NCT03855800 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 3,246 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Pancreas Cyst appearing as the primary indexed condition, and to 3 interventions — of which Blood, stool, pancreatic juice and cyst fluid collection is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03855800 reports 1 study location spanning 1 distinct geographic area — top geographies include Minnesota. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03855800 about?

NCT03855800 is a clinical study titled "Molecular Detection of Advanced Neoplasia in Pancreatic Cysts". Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.

What is the current status of trial NCT03855800?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2018-05-11. Estimated completion is 2030-12-30.

What conditions does trial NCT03855800 study?

This clinical trial studies the following conditions: Pancreas Cyst. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03855800?

The interventions under investigation include: Blood, stool, pancreatic juice and cyst fluid collection (DIAGNOSTIC_TEST), Pancreatic Surgery (PROCEDURE), Endoscopy Exam (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03855800?

This trial is sponsored by Mayo Clinic, which has 3,246 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03855800 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial